8-K: Henry Schein Reports Mixed Q4 2023 Results, Introduces 2024 Guidance

Henry Schein's fourth-quarter results were impacted by a cybersecurity incident, but the company is projecting strong growth for 2024.

Summary

• Henry Schein reported a 10.5% decrease in total net sales for the fourth quarter of 2023, reaching $3.0 billion, compared to the same period in 2022.
• This decrease includes an estimated $350 million to $400 million reduction due to a cybersecurity incident.
• The company's GAAP net income for the quarter was $18 million, or $0.13 per diluted share, while non-GAAP net income was $86 million, or $0.66 per diluted share.
• For the full year 2023, total net sales were $12.3 billion, a 2.4% decrease compared to 2022.
• Full-year GAAP net income was $416 million, or $3.16 per diluted share, and non-GAAP net income was $593 million, or $4.50 per diluted share.
• Henry Schein invested $287 million in acquisitions in the fourth quarter and $955 million for the full year 2023.
• The company repurchased approximately 692,000 shares in Q4 and 3.2 million shares for the full year.
• Henry Schein introduced 2024 guidance, projecting non-GAAP diluted EPS of $5.00 to $5.16, reflecting 11% to 15% growth compared to 2023.
• The company also expects 2024 sales growth of approximately 8% to 12% and Adjusted EBITDA growth of more than 15%.

Sentiment

Score: 5

Explanation: The document presents mixed results, with a significant negative impact from the cybersecurity incident, but also positive forward-looking guidance. The sentiment is neutral to slightly negative due to the past performance issues.

Positives

• The company's 2024 guidance projects strong growth in non-GAAP diluted EPS and Adjusted EBITDA.
• The Technology and Value-Added Services businesses showed strong growth in the fourth quarter.
• Global sales of implants and biomaterials were strong, driven by acquisitions.
• The company is actively investing in acquisitions to accelerate its strategic plan.
• Henry Schein has a significant amount authorized for future stock repurchases.

Negatives

• The cybersecurity incident had a significant negative impact on fourth-quarter sales, reducing total net sales by an estimated $350 million to $400 million.
• Fourth-quarter GAAP net income decreased significantly compared to the same period in 2022.
• Full-year 2023 sales and net income decreased compared to 2022.
• The company experienced higher-than-usual acquisition-related expenses and adjustments in the fourth quarter.
• The cybersecurity incident is expected to have a residual impact on merchandise sales in 2024, primarily in the first quarter.

Risks

• The company is still recovering from the cybersecurity incident, which is expected to have a residual impact on sales in 2024.
• The company faces risks related to the integration of acquisitions and the achievement of anticipated synergies.
• The company is exposed to risks related to cyberattacks and data security breaches.
• The company operates in a highly competitive and consolidating market.
• The company is subject to various regulatory requirements and risks associated with global operations.

Future Outlook

Henry Schein expects 2024 non-GAAP diluted EPS to be between $5.00 and $5.16, reflecting growth of 11% to 15% compared with 2023. Sales growth is expected to be approximately 8% to 12%, and Adjusted EBITDA is expected to increase by more than 15%.

Management Comments

• We are pleased with our performance in the fourth quarter and for the full year 2023, which was in line with our expectations and reflects a solid recovery from last year's cybersecurity incident, said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.
• Our fourth quarter financial results included strong growth in our Technology and Value-Added Services businesses, and in global sales of implants and biomaterials largely driven by acquisitions, and were negatively impacted by higher-than-usual acquisition-related expenses and adjustments, Mr. Bergman said.
• The 2024 guidance we are introducing today reflects our continued confidence in the stability of the underlying markets we serve, our recovery efforts from the cybersecurity incident, and the execution of our Strategic Plan.

Industry Context

The healthcare solutions industry is competitive, with companies focusing on technology and value-added services. Henry Schein's results reflect the challenges of cybersecurity incidents and the need for strategic acquisitions to drive growth. The company's focus on higher-growth, higher-margin products and services aligns with industry trends.

Comparison to Industry Standards

• Henry Schein's performance is being compared to its own previous results, with a focus on recovery from the cybersecurity incident.
• The company's growth in Technology and Value-Added Services is a positive sign, as this is a key area of focus for many healthcare companies.
• The impact of the cybersecurity incident is a significant factor, and the company's ability to recover will be closely watched.
• The company's 2024 guidance is a key indicator of its future performance, and the projected growth rates are important for investors to consider.
• Comparisons to other healthcare distribution companies would be needed to fully assess Henry Schein's performance against industry benchmarks, but this document does not provide that information.

Stakeholder Impact

• Shareholders will be impacted by the decreased sales and earnings in 2023, but may be encouraged by the 2024 guidance.
• Employees may be affected by restructuring and integration costs.
• Customers may have experienced disruptions due to the cybersecurity incident.
• Suppliers may be impacted by changes in purchasing patterns.
• Creditors will be monitoring the company's financial performance and recovery efforts.

Next Steps

• The company will hold a conference call to discuss the fourth-quarter and full-year 2023 financial results.
• The company will continue to execute on its BOLD+1 Strategic Plan.
• The company will focus on recovering from the cybersecurity incident and strengthening its market position.

Key Dates

Keywords

Henry Schein, financial results, cybersecurity incident, non-GAAP EPS, Adjusted EBITDA, acquisitions, stock repurchase, healthcare solutions, dental, medical